Susquehanna International Group, LLP United Therapeutics Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $12.6 Million - $14.7 Million	40,400 Added 34.83%	156,400 $56 Million
Q2 2024 Aug 15, 2024	BUY	$228.26 - $319.04 $3.45 Million - $4.82 Million	15,100 Added 14.97%	116,000 $37 Million
Q1 2024 May 07, 2024	BUY	$210.76 - $249.51 $14.2 Million - $16.8 Million	67,300 Added 200.3%	100,900 $23.2 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $5.69 Million - $6.81 Million	-26,500 Reduced 44.09%	33,600 $7.39 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $3.69 Million - $4.32 Million	17,400 Added 40.75%	60,100 $13.6 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $3.67 Million - $4.17 Million	-17,900 Reduced 29.54%	42,700 $9.43 Million
Q1 2023 May 16, 2023	BUY	$212.99 - $276.17 $3.88 Million - $5.03 Million	18,200 Added 42.92%	60,600 $13.6 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $2.74 Million - $3.73 Million	-13,300 Reduced 23.88%	42,400 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $121,980 - $146,502	600 Added 1.09%	55,700 $11.7 Million

667

42.7M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.